Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

March 21 - 22, 2014

San Francisco, California

Scientific Agenda

Friday, March 21, 2013

Master Class: Management of IBD in Children, Teens, and Young Adults

Co-Chairs: Joel R. Rosh, MD and Robbyn E. Sockolow, MD

1:00 pm

Welcome and pre-activity audience knowledge/competence assessment via ARS
Robbyn E. Sockolow, MD

1:15 pm

Risk stratification of pediatric IBD: What disease phenotype does your patient really have?
Mel Heyman, MD

1:45 pm

Enzymes, levels, monitoring of mucosal and transmural healing—how to optimize
immunomodulators and biologics in pediatric IBD
Marla C. Dubinsky, MD

2:15 pm

Faculty panel: Putting it all together—how do you really treat a new pediatric IBD patient?
All pediatric faculty
Moderator: Robbyn E. Sockolow, MD

2:45 pm

Coffee break

3:05 pm

Caring for the adolescent IBD patient: Bone health, sexuality and preparing for transition of care
Francisco Sylvester, MD

3:35 pm

You are what you eat: Nutrition, worms, stool and emerging therapies
Joel R. Rosh, MD

4:05 pm

Faculty panel: What are today’s emerging therapies and how should they be evaluated?
Lessons from the GREAT Workshops
All pediatric faculty
Moderator: Joel R. Rosh, MD

4:35 pm

Challenging cases in IBD—preparing for the unexpected
All pediatric faculty
Moderator: Robbyn E. Sockolow, MD

5:00 pm


Saturday, March 22, 2014

Practical Insights in the Management of Adult IBD

Moderators: Marla C. Dubinsky, MD, and Uma Mahadevan, MD

7:00 am


8:00 am

Welcome and pre-activity audience knowledge/competence assessment via ARS
Marla C. Dubinsky, MD, Uma Mahadevan, MD

8:15 am

Safety of medications during pregnancy and breastfeeding
Uma Mahadaven, MD

8:35 am

Health maintenance: Impact of quality measures
Caroline Hwang, MD

8:55 am

Q and A

9:05 am

Translating IBD genetics to IBD practice
Dermot McGovern, MD, PhD

9:25 am

Out of the Box therapies: FMT, cannabis, worms
David Rubin, MD

9:35 am


9:45 am

Coffee break

10:00 am

Future targets and how they will be used in practice
Miguel Regueiro, MD, AGAF, FACG

10:20 am

Therapeutic drug monitoring
Marla Dubinsky, MD

10:40 am

Q and A

10:50 am

Debate: Immunobiologics and biologics must be stopped before surgery vs. not
10:50 – 11:00 - Point: Stopped before surgery
Emily Finlayson, MD

11:00 – 11:10 - Counterpoint: No need to stop
Fernando Velayos, MD

11:00 am

Counterpoint: No need to stop:

11:10 am


11:20 am

Debate: Post-operative management of IBD


11:20 – 11:30 – Point: Treatment should be started right after surgery
Miguel Regueiro, MD

11:30 – 11:40 – Counterpoint: Treatment should be started after 6 month colonoscopy
Dermot McGovern, MD, PhD

11:40 am


11:50 am

Panel discussion: Frequently asked questions
All Adult IBD faculty

12:15 pm

Meet the Experts – Lunch Discussion

1:15 pm

Debate: Mucosal healing should be the primary outcome in UC
1:15 - 1:25 – Point: Yes
David Rubin, MD

1:25-1:35 – Counterpoint: No:
Uma Mahadevan, MD

1:35 pm


1:45 pm

Debate: Dysplasia and polyps in UC: Is colectomy the only answer?
1:45 – 1:55 – Point: Yes:
Emily Finlayson, MD

1:55 – 2:05 – Counterpoint: No:
Fernando Velayos, MD

2:05 pm


2:15 pm

Coffee break

2:40 pm

Gastroenterology Board review – Clinical cases and questions for the practicing gastroenterologist and GI Fellow preparing for Board certification or recertification
Moderators: Marla C. Dubinsky, MD, Uma Mahadevan, MD
All Adult IBD faculty

3:40 pm

Conclusion and wrap-up summary

3:45 pm